Completed
A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis
NCT00814307
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Gilbert, Arizona, United States
- Pfizer Investigational Site Tucson, Arizona, United States
- Pfizer Investigational Site Hot Springs, Arkansas, United States
- Pfizer Investigational Site Jacksonville, Florida, United States